Scott Fidel
Stock Analyst at Stephens & Co.
(1.63)
# 3,351
Out of 4,959 analysts
171
Total ratings
40%
Success rate
2.33%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Scott Fidel
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
ARDT Ardent Health | Reiterates: Overweight | $21 | $12.98 | +61.79% | 5 | May 20, 2025 | |
ADUS Addus HomeCare | Reiterates: Overweight | $142 | $118.41 | +19.92% | 12 | Mar 12, 2025 | |
PNTG The Pennant Group | Reiterates: Overweight | $38 | $25.17 | +50.97% | 18 | Mar 11, 2025 | |
UHS Universal Health Services | Maintains: Equal-Weight | $210 → $223 | $185.58 | +20.16% | 10 | Feb 28, 2025 | |
ALHC Alignment Healthcare | Reiterates: Overweight | $17 | $15.84 | +7.32% | 5 | Jan 2, 2025 | |
CNC Centene | Maintains: Equal-Weight | $75 → $73 | $29.41 | +148.21% | 9 | Dec 13, 2024 | |
UNH UnitedHealth Group | Maintains: Overweight | $605 → $675 | $307.42 | +119.57% | 22 | Dec 5, 2024 | |
PACS PACS Group | Maintains: Overweight | $48 → $31 | $12.05 | +157.26% | 4 | Nov 18, 2024 | |
CI The Cigna Group | Reiterates: Overweight | $410 | $304.35 | +34.71% | 12 | Nov 1, 2024 | |
ENSG The Ensign Group | Maintains: Overweight | $163 → $167 | $172.44 | -3.15% | 9 | Oct 28, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $21 | $25.79 | -18.57% | 1 | Oct 22, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Equal-Weight | $250 | $299.51 | -16.53% | 7 | Oct 9, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $615 | $316.55 | +94.28% | 3 | Sep 5, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $105 | $122.83 | -14.52% | 10 | Aug 6, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Equal-Weight | $320 | $174.44 | +83.44% | 9 | Jul 25, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $95 → $122 | $179.50 | -32.03% | 10 | May 1, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $92 | $22.44 | +309.98% | 9 | Jan 5, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $280 | $404.97 | -30.86% | 9 | Nov 10, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $95 | $1.07 | +8,778.50% | 4 | Jun 27, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $2.25 → $1.5 | $7.47 | -79.92% | 3 | Nov 11, 2022 |
Ardent Health
May 20, 2025
Reiterates: Overweight
Price Target: $21
Current: $12.98
Upside: +61.79%
Addus HomeCare
Mar 12, 2025
Reiterates: Overweight
Price Target: $142
Current: $118.41
Upside: +19.92%
The Pennant Group
Mar 11, 2025
Reiterates: Overweight
Price Target: $38
Current: $25.17
Upside: +50.97%
Universal Health Services
Feb 28, 2025
Maintains: Equal-Weight
Price Target: $210 → $223
Current: $185.58
Upside: +20.16%
Alignment Healthcare
Jan 2, 2025
Reiterates: Overweight
Price Target: $17
Current: $15.84
Upside: +7.32%
Centene
Dec 13, 2024
Maintains: Equal-Weight
Price Target: $75 → $73
Current: $29.41
Upside: +148.21%
UnitedHealth Group
Dec 5, 2024
Maintains: Overweight
Price Target: $605 → $675
Current: $307.42
Upside: +119.57%
PACS Group
Nov 18, 2024
Maintains: Overweight
Price Target: $48 → $31
Current: $12.05
Upside: +157.26%
The Cigna Group
Nov 1, 2024
Reiterates: Overweight
Price Target: $410
Current: $304.35
Upside: +34.71%
The Ensign Group
Oct 28, 2024
Maintains: Overweight
Price Target: $163 → $167
Current: $172.44
Upside: -3.15%
Oct 22, 2024
Initiates: Overweight
Price Target: $21
Current: $25.79
Upside: -18.57%
Oct 9, 2024
Reiterates: Equal-Weight
Price Target: $250
Current: $299.51
Upside: -16.53%
Sep 5, 2024
Reiterates: Overweight
Price Target: $615
Current: $316.55
Upside: +94.28%
Aug 6, 2024
Reiterates: Overweight
Price Target: $105
Current: $122.83
Upside: -14.52%
Jul 25, 2024
Reiterates: Equal-Weight
Price Target: $320
Current: $174.44
Upside: +83.44%
May 1, 2024
Maintains: Equal-Weight
Price Target: $95 → $122
Current: $179.50
Upside: -32.03%
Jan 5, 2024
Upgrades: Overweight
Price Target: $92
Current: $22.44
Upside: +309.98%
Nov 10, 2023
Reiterates: Overweight
Price Target: $280
Current: $404.97
Upside: -30.86%
Jun 27, 2023
Reiterates: Overweight
Price Target: $95
Current: $1.07
Upside: +8,778.50%
Nov 11, 2022
Maintains: Equal-Weight
Price Target: $2.25 → $1.5
Current: $7.47
Upside: -79.92%